In HCC and ESCC, the expression of AJAP1 was also found to be reduced due to promotor hyper-methylation and loss of copy number, suggesting that AJAP1 acts as a tumor suppressor (Ezaka et al., 2015; Tanaka et al., 2015). This evidence concerns the gene AJAP1 and hepatocellular carcinoma.